Therapy fields in development pipelines in German biotech companies 2013
This statistic shows the share of therapy fields in the clinical and preclinical development pipeline in biotech companies in Germany as of 2013. That year, oncology comprised 56 percent of all therapy fields in clinical development in Germany.